Design, synthesis, and antibacterial evaluation of new Schiff’s base derivatives bearing nitroimidazole and pyrazole nuclei as potent E. coli FabH inhibitors

[1]  Hai‐Liang Zhu,et al.  Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors. , 2013, Bioorganic & medicinal chemistry letters.

[2]  Xiao-Ming Wang,et al.  Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors. , 2013, Bioorganic & medicinal chemistry.

[3]  Shuai Zhang,et al.  Synthesis and Antimicrobial Activities of Oximes Derived from O‐Benzylhydroxylamine as FabH Inhibitors , 2012, ChemMedChem.

[4]  H.-L. Zhu,et al.  Advances in the research of β-ketoacyl-ACP synthase III (FabH) inhibitors. , 2012, Current medicinal chemistry.

[5]  Manish P. Patel,et al.  Synthesis and in vitro antimicrobial screening of new pyrano[4,3-b]pyrane derivatives of 1H-pyrazole , 2012 .

[6]  Xiao-Ming Wang,et al.  Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea. , 2011, Bioorganic & medicinal chemistry.

[7]  Hong-Jia Zhang,et al.  Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors. , 2011, Bioorganic & medicinal chemistry.

[8]  Yin Luo,et al.  Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors. , 2010, Bioorganic & medicinal chemistry letters.

[9]  Yin Luo,et al.  Design, Synthesis, and Immunosuppressive Activity of New Deoxybenzoin Derivatives , 2010, ChemMedChem.

[10]  Yin Luo,et al.  Metronidazole–Deoxybenzoin Derivatives as Anti‐Helicobacter pylori Agents with Potent Inhibitory Activity against HPE‐Induced Interleukin‐8 , 2010, ChemMedChem.

[11]  Zheng Gu,et al.  Synthesis of substituted-phenyl-1,2,4-triazol-3-thione analogues with modified D-glucopyranosyl residues and their antiproliferative activities. , 2009, European journal of medicinal chemistry.

[12]  Yin Luo,et al.  Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics. , 2009, Bioorganic & medicinal chemistry.

[13]  Soyoung Shin,et al.  Antimicrobial natural products as beta-ketoacyl-acyl carrier protein synthase III inhibitors. , 2009, Bioorganic & medicinal chemistry.

[14]  Kerly F. M. Pasqualoto,et al.  Design, synthesis, antimicrobial activity and molecular modeling studies of novel benzofuroxan derivatives against Staphylococcus aureus. , 2009, Bioorganic & medicinal chemistry.

[15]  S. Cai,et al.  Discovery of substituted N′-(2-oxoindolin-3-ylidene)benzohydrazides as new apoptosis inducers using a cell- and caspase-based HTS assay , 2009, Bioorganic & Medicinal Chemistry Letters.

[16]  K. Jeong,et al.  Novel E. coli beta-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics. , 2009, Bioorganic & medicinal chemistry.

[17]  Y. Uehara,et al.  Design of antiangiogenic hypoxic cell radiosensitizers: 2-nitroimidazoles containing a 2-aminomethylene-4-cyclopentene-1,3-dione moiety. , 2008, Bioorganic & medicinal chemistry.

[18]  A. Shafiee,et al.  Convenient syntheses of 5-[(2-methyl-5-nitro-1H-imidazol-1-yl)methyl]-1,3,4-oxadiazole-2(3H)thione and N-substituted 2-amino-5-[(2-methyl-5-nitro-1H-imidazol-1-yl)methyl]-1,3,4-thiadiazoles , 2008 .

[19]  A. Henriksen,et al.  Structure of the human β‐ketoacyl [ACP] synthase from the mitochondrial type II fatty acid synthase , 2006, Protein science : a publication of the Protein Society.

[20]  Jun Yin,et al.  Inhibitory study of some novel Schiff base derivatives on Staphylococcus aureus by microcalorimetry , 2006 .

[21]  N. Petrovsky,et al.  Immunoinformatics and its relevance to understanding human immune disease , 2005, Expert review of clinical immunology.

[22]  K. Reynolds,et al.  1,2-Dithiole-3-Ones as Potent Inhibitors of the Bacterial 3-Ketoacyl Acyl Carrier Protein Synthase III (FabH) , 2004, Antimicrobial Agents and Chemotherapy.

[23]  S. Khandekar,et al.  Bacterial beta-ketoacyl-acyl carrier protein synthases as targets for antibacterial agents. , 2003, Current protein & peptide science.

[24]  R. Puupponen-Pimiä,et al.  Antimicrobial properties of phenolic compounds from berries , 2001, Journal of applied microbiology.

[25]  H. Novoa de Armas,et al.  Physico-chemical and solid-state characterization of secnidazole. , 2000, Farmaco.

[26]  R. Heath,et al.  Roles of the FabA and FabZ β-Hydroxyacyl-Acyl Carrier Protein Dehydratases in Escherichia coli Fatty Acid Biosynthesis* , 1996, The Journal of Biological Chemistry.

[27]  R. Heath,et al.  Regulation of Fatty Acid Elongation and Initiation by Acyl-Acyl Carrier Protein in Escherichia coli(*) , 1996, The Journal of Biological Chemistry.